Skip to main content
OpenTrials
Completed

NCT Number: NCT01408875

Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure

The purpose of this study is to determine if addition of low frequency electro-myo-stimulation to cardiac rehabilitation is effective to improve exercise capacity and/or muscular strength in chronic heart failure patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre de réadaptation spécialisé Saint Luc, Abreschviller, France

Loading trial locations.

About this study

In chronic heart failure, low exercise capacity is due, in part, to peripheral muscles abnormalities. Exercise training performed during cardiac rehabilitation improves exercise tolerance measured by cardiopulmonary exercise test. Low frequency electromyostimulation (EMS) was proposed as an alternative to exercise training (ET) in this population.

However, the effectiveness of the combination (EMS +ET) compared with ET alone is not proved. The main objective is to compare exercise capacity judged by peak VO2 after treatment by ET alone versus EMS+ET. The secondary end points are results on sub maximal parameters, muscular resistance, quality of life and effectiveness regarding clinical sub-groups.

This study is a controlled, randomized, multicentric (14 centres) designed to include 90 patients by group in two years period. Inclusion criteria are: CHF patients , NYHA class II to IIIb, with LVEF < 40% referred to complete a cardiac rehabilitation program.

All the patients benefit from a comprehensive cardiac rehabilitation program including educational program, therapeutical optimisation and exercise training for 20 sessions, 3 to 5 days a week. The group of patients randomized for additional EMS has 20 sessions of 1 hour electrical quadricipital myostimulation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age from 18 to 75 yo
  • stable Chronic Heart Failure (CHF) under "optimal" treatment since at least 1 week
  • NYHA functional class II to IIIb
  • left ventricular ejection fraction < 40%
  • cardiopulmonary exercise test feasible
  • whatever etiology of heart failure
  • age of heart failure ≥ 3 months.
  • have signed the consent document to participate in the study

Exclusion criteria

  • previous treatment by functional electrical myo stimulation
  • recent acute heart failure or inotropic intravenous agents used (< 10 days)
  • recent coronary angioplasty (< 10 days)
  • cardiac surgery < 1 month
  • valvular disease requiring surgical treatment
  • uncontrolled hypertension (≥ systolic 180 and/or diastolic 110 mmHg)
  • severe respiratory insufficiency (VEMS < 1000 ml)
  • pregnancy
  • Automatic implantable defibrillator
  • pace-makers : cardiac stimulation dependence or not known
  • incapacity to achieve 6 min walk test and/or exercise testing
  • absolute contra-indication to exercise test and/or exercise training
  • myocarditis or pericarditis
  • uncontrolled ventricular arrhythmias
  • Obesity (BMI ≥ 35)
  • known and documented peripheral myopathy
  • participation to another study protocol
  • patient incapable of giving consent

Treatment and study plan

Low electrical myostimulation

Device

The group of patients randomized for additional EMS will have 20 sessions of 1 hour electrical quadricipital myostimulation.

Primary outcomes

  1. Peak VO2

    Time frame: at inclusion (baseline) then after 4 to 7 weeks of cardiac rehabilitation

    The primary outcome is the improvement of peak VO2 estimated by relative changes between before and at the end of the cardiac rehabilitation program.

Secondary outcomes

  1. Changes on muscular strength

    Time frame: at inclusion then after 4 to 7 weeks of cardiac rehabilitation

    Measure of weight that the patient can lift 3 times but not four with quadriceps.

  2. Changes on sub maximal parameters

    Time frame: at inclusion then after 4 to 7 weeks of cardiac rehabilitation

    Measure of ventilatory threshold and walk test of 6 min.

  3. Modifications of quality of life

    Time frame: at inclusion then after 4 to 7 weeks of cardiac rehabilitation

    Minnesota questionnaire completed by the patient

Sponsors and collaborators

Lead sponsor

French Cardiology Society

Other

Collaborators

  • Bourgogne Association of Cardiology
  • Gulf Estuarine Research Society (GERS)
  • Ile-de-France Association of Cardiology

Registry information

Acronym: CREMS-HF

Important dates

Study start
2011
Primary completion
2013
Study completion
2014
First posted
Aug 3, 2011
Registry last updated
Mar 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.